A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

NCT02119260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Oedema, Pulmonary

Interventions

DRUG: GSK2798745 solution
DRUG: GSK2798745 suspension
DRUG: GSK2798745 capsule
DRUG: Placebo solution
DRUG: Placebo suspension
DRUG: Placebo capsule

Sponsor

GlaxoSmithKline